EP.12A.41 First-Line Treatment of EGFR-Mutant NSCLC: TKI Alone or Combinations - What I Use Today and Why in the Latin America vs the World

Autor: Bon, G.V., de Laia, E.A., Peixoto, C.M., Trotte, G.B., de Oliveira, C.V.Y., Silvestre, G.P., da Costa, P.H.A., Dias, R.T., Martins, L.F.d.L., Silva, C.D.C.e., dos Santos, V.M.L.
Zdroj: In Journal of Thoracic Oncology October 2024 19(10) Supplement:S638-S638
Databáze: ScienceDirect